Advanced search
Publication Cover
Vascular Health and Risk Management Volume 8, 2012 - Issue
Submit an article Journal homepage
73
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers

Elaine Chiquette1 Amylin Pharmaceuticals, San Diego, CACorrespondence[email protected]
,
Peter P Toth2 University of Illinois, Peoria, IL
,
Gilbert Ramirez3 Florida International University, Miami, FL
,
Michael Cobble4 Atherotech, Birmingham, AL
&
Robert Chilton5 University of Texas, San Antonio, TX, USA
Pages 621-629 | Published online: 12 Nov 2012

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.